Inventor · disambiguated record
Ruben Gerardus George Leenders
Also filed as: HEERES JAN · LEENDERS RUBEN · LEENDERS RUBEN G G · LEENDERS RUBEN GERARDUS GEORGE
11 granted patents·4 pending applications·136 citations·filing 1996–2025
89Inventor score
Files withJANSSEN PHARMACEUTICA NV5IMMUNEERING CORP3PHARMACHEMIE BV2UNIV OSLO HF2JANSSEN PHARMACEUTICA INC1
Top patents by PatentIndex Score
15 records- 0185US7705148B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Apr 27, 2010·7 cites·9 claims
- 0285US7399856B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 15, 2008·19 cites·12 claims
- 0385US7276510B2HIV replication inhibitorsJANSSEN PHARMACEUTICA INC·Filed 2001·Granted Oct 2, 2007·27 cites·49 claims
- 0484US7563922B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 21, 2009·6 cites·6 claims
- 0584US5710135AAnthracycline prodrugs, method for preparation as well as their use in selective chemotherapyPHARMACHEMIE BV·Filed 1996·Granted Jan 20, 1998·44 cites·9 claims
- 0681US5760072APaclitaxel prodrugs, method for preparation as well as their use in selective chemotherapyPHARMACHEMIE BV·Filed 1996·Granted Jun 2, 1998·26 cites·5 claims
- 0778US9388156B2Chromanyl derivatives for treating mitochondrial diseaseKHONDRION IP B V·Filed 2013·Granted Jul 12, 2016·6 cites·17 claims
- 0871US11926614B21,2,4-triazole derivatives as tankyrase inhibitorsUNIV OSLO HF·Filed 2019·Granted Mar 12, 2024·1 cites·23 claims
- 0958US12351566B2MEK inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2021·Granted Jul 8, 2025·0 cites·21 claims
- 1057US2025270180A1Mek inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2025·Application pending·0 cites
- 1156US2024300904A1Pyridazinones for the treatment or prevention of hypertensionUNIV OSLO·Filed 2022·Application pending·0 cites
- 1251US2025179057A1Mek immune oncology inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2023·Application pending·0 cites
- 1350US2023322721A1Triazole derivatives and their use as tankyrase inhibitorsUNIV OSLO HF·Filed 2021·Application pending·0 cites
- 1445US7585861B2HIV inhibiting 1,2,4-triazinesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 8, 2009·0 cites·19 claims
- 1542US8026245B2HIV replication inhibiting purine derivativesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 27, 2011·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →